Abstract:In our study, in geriatric patient group colistin nephrotoxicity was not different from the younger age group. In the ICU, the age for nephrotoxicity does not appear to be a point to be considered for the initiation of colistin.
“…Although some studies demonstrated higher mortality in patients with COL nephrotoxicity, others showed no difference (3,19,20).Özkarakaş et al reported similar mortality rates between patients with and without nephrotoxicity (19). In another study comparing mortality rates in older and young adult patients receiving COL, there was no difference between the two groups (5). In contrast to these findings, mortality rates were statistically higher in the nephrotoxicity group and in the geriatric nephrotoxicity subgroup in our study.…”
Section: Discussioncontrasting
confidence: 89%
“…Aydogan et al reported higher rates of cardiac disease and COPD in the geriatric group but it was found that advanced age is not a risk factor for nephrotoxicity. (5). In our study, no significant difference was found between geriatric and young patients who developed nephrotoxicity in terms of underlying chronic diseases, concomitant nephrotoxic agent use, initial serum urea and creatinine values.…”
Section: Discussioncontrasting
confidence: 54%
“…Being treated in intensive care units (ICUs) and older age are factors that increase the frequency of infections caused by resistant microorganisms and complicate the management of the antimicrobial agents used. Some studies have shown that COL nephrotoxicity increases with age, while no relationship between age and COL-related renal toxicity was detected in others (5)(6)(7)(8)(9). The present study aimed to identify risk factors associated with COL nephrotoxicity in the general population and geriatric patients hospitalized in the ICUs of our hospital.…”
Section: Introductionmentioning
confidence: 84%
“…One of these studies showed that nephrotoxicity frequently occurred in the first 72 hours after starting COL (7). In another study investigating COL nephrotoxicity in older and younger adult patients, it was observed that older patients had a significantly longer length of ICU stay before COL initiation (5). When geriatric and young patients were compared in terms of time from onset of COL to nephrotoxicity, there was no statistically significant difference.…”
Introduction: The population is aging and older adults comprise the
majority of patients in intensive care units. Colistin (COL) has been
reintroduced to treat increasingly common resistant Gram-negative
bacterial infections. Our study aims to investigate the factors
affecting colistin nephrotoxicity in the general population and
geriatric age group. Materials and Method: This retrospective study
included 170 patients, 116 (68.2%) of which were in the geriatric group
(age ≥65). Acute renal failure was evaluated using the RIFLE score.
Firstly, factors associated with COL nephrotoxicity in the general
population were investigated. Then, risk factors for COL nephrotoxicity
were evaluated in the geriatric patient group. Results: Advanced age
(odds ratio [OR]=1.043; 95% confidence interval [CI]:
1.018-1.068; p=0.001) and initial serum creatinine level (OR=23.122;
95% CI: 3.123-171.217; p=0.002) were found to be independent risk
factors associated with nephrotoxicity. In the evaluation of the
geriatric population-based on nephrotoxicity, the initial serum urea and
creatinine levels, immunosuppression, and overall mortality rates were
found to be statistically significant in the group with nephrotoxicity
(p<0.05). Initial serum creatinine level (OR=22.48; 95% CI:
2.835-178.426; p=0.003) and concomitant nephrotoxic agent use (OR=2.516;
95% CI: 1.275-4.963; p=0.008) were independent risk factors associated
with nephrotoxicity in geriatric patients. Conclusion: Advanced age was
found to be a risk factor for COL nephrotoxicity. Caution should be
exercised especially in geriatric patients who have initial serum
creatinine levels close to the upper limit, concomitant use of
nephrotoxic drugs should be avoided and if possible, evaluation should
be made in terms of non-COL treatment options in these patients.
“…Although some studies demonstrated higher mortality in patients with COL nephrotoxicity, others showed no difference (3,19,20).Özkarakaş et al reported similar mortality rates between patients with and without nephrotoxicity (19). In another study comparing mortality rates in older and young adult patients receiving COL, there was no difference between the two groups (5). In contrast to these findings, mortality rates were statistically higher in the nephrotoxicity group and in the geriatric nephrotoxicity subgroup in our study.…”
Section: Discussioncontrasting
confidence: 89%
“…Aydogan et al reported higher rates of cardiac disease and COPD in the geriatric group but it was found that advanced age is not a risk factor for nephrotoxicity. (5). In our study, no significant difference was found between geriatric and young patients who developed nephrotoxicity in terms of underlying chronic diseases, concomitant nephrotoxic agent use, initial serum urea and creatinine values.…”
Section: Discussioncontrasting
confidence: 54%
“…Being treated in intensive care units (ICUs) and older age are factors that increase the frequency of infections caused by resistant microorganisms and complicate the management of the antimicrobial agents used. Some studies have shown that COL nephrotoxicity increases with age, while no relationship between age and COL-related renal toxicity was detected in others (5)(6)(7)(8)(9). The present study aimed to identify risk factors associated with COL nephrotoxicity in the general population and geriatric patients hospitalized in the ICUs of our hospital.…”
Section: Introductionmentioning
confidence: 84%
“…One of these studies showed that nephrotoxicity frequently occurred in the first 72 hours after starting COL (7). In another study investigating COL nephrotoxicity in older and younger adult patients, it was observed that older patients had a significantly longer length of ICU stay before COL initiation (5). When geriatric and young patients were compared in terms of time from onset of COL to nephrotoxicity, there was no statistically significant difference.…”
Introduction: The population is aging and older adults comprise the
majority of patients in intensive care units. Colistin (COL) has been
reintroduced to treat increasingly common resistant Gram-negative
bacterial infections. Our study aims to investigate the factors
affecting colistin nephrotoxicity in the general population and
geriatric age group. Materials and Method: This retrospective study
included 170 patients, 116 (68.2%) of which were in the geriatric group
(age ≥65). Acute renal failure was evaluated using the RIFLE score.
Firstly, factors associated with COL nephrotoxicity in the general
population were investigated. Then, risk factors for COL nephrotoxicity
were evaluated in the geriatric patient group. Results: Advanced age
(odds ratio [OR]=1.043; 95% confidence interval [CI]:
1.018-1.068; p=0.001) and initial serum creatinine level (OR=23.122;
95% CI: 3.123-171.217; p=0.002) were found to be independent risk
factors associated with nephrotoxicity. In the evaluation of the
geriatric population-based on nephrotoxicity, the initial serum urea and
creatinine levels, immunosuppression, and overall mortality rates were
found to be statistically significant in the group with nephrotoxicity
(p<0.05). Initial serum creatinine level (OR=22.48; 95% CI:
2.835-178.426; p=0.003) and concomitant nephrotoxic agent use (OR=2.516;
95% CI: 1.275-4.963; p=0.008) were independent risk factors associated
with nephrotoxicity in geriatric patients. Conclusion: Advanced age was
found to be a risk factor for COL nephrotoxicity. Caution should be
exercised especially in geriatric patients who have initial serum
creatinine levels close to the upper limit, concomitant use of
nephrotoxic drugs should be avoided and if possible, evaluation should
be made in terms of non-COL treatment options in these patients.
“…The rise and dissemination of multidrug-resistant (MDR) Enterobacteriaceae, especially carbapenem-resistant Enterobacteriaceae (CRE), with mechanisms such as NDM-1, KPC, and OXA-48/181 in the last few decades have led to urgent challenges in the clinical treatment of MDR or extensively drug-resistant (XDR) pathogen diseases (1, 2). In this case, despite having a side effect of nephrotoxicity, colistin is still considered a last-resort antibiotic in the clinical treatment of serious infections caused by CRE (3). However, mobile colistin resistance (MCR), referring to a plasmid-mediated gene encoding a phosphoethanolamine transferase conferring resistance to colistin, was initially reported in 2015 in China and named mcr-1 ( m obile c olistin r esistance 1) (4).…”
Seven Salmonella enterica subsp. enterica isolates were identified as carrying the mcr-1 gene, by using a real-time fluorescence quantitative PCR method, from a total of 2,558 isolates which were cultured from various food origins in China between 2011 and 2016. Few complete genomes of Salmonella strains harboring the mcr-1 gene have been reported to date, so we report here the complete genome and plasmid sequences of all of these isolates to provide useful references for understanding the prevalence of foodborne Salmonella enterica subsp. enterica isolates carrying mcr-1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.